This study investigates treatment options for advanced liver cancer, specifically hepatocellular carcinoma (HCC). HCC is a type of liver cancer that occurs in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. The study aims to explore the effectiveness of certain therapies in patients with this condition.

Participants in the study will undergo various procedures, including imaging tests and possibly liver biopsies to confirm the diagnosis. The study will involve treatment with investigational medications, and medical examinations will be conducted to monitor the participants' health and response to the treatment.

• Who can participate: Participants must have advanced hepatocellular carcinoma confirmed by imaging or liver biopsy and be eligible for specific therapy. They should have good liver function and a performance status of 2 or less.
• Study details: Participants will receive investigational medications and undergo regular health assessments to monitor liver function and any side effects.